Results 121 to 130 of about 38,480 (291)
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies [PDF]
Pancras C. Wong +7 more
openalex +1 more source
Association of Anaesthetists guidelines: safe vascular access 2025
Summary Introduction Safe vascular access is integral to anaesthetic and critical care practice. However, despite technological and procedural advances, it remains a frequent source of adverse events and patient harm. Ensuring a safe and effective approach to the selection, insertion and care of vascular access devices should be a priority for all ...
Andrew J. Johnston +13 more
wiley +1 more source
Adjustment for ‘Prescriber Type’ in Pharmacoepidemiological Analyses
ABSTRACT The type of prescriber typically fulfils the criteria for confounding, as it is associated both with the exposure (e.g., prescriber types may differ in their choice of first‐line treatment) and with the outcome (as different types of prescribers often treat patients with different disease severity).
Saad Hanif Abbasi +4 more
wiley +1 more source
Objective: A recent clinical trial demonstrated that the use of apixaban was safe and equal to enoxaparin (LMWH) in post-operative gynecologic oncology patients.
Victoria Diamond +5 more
doaj +1 more source
Letter to the Editor: Pharmacokinetics of apixaban [PDF]
Penny Beirne, Paul Chin, Matthew Doogue
openaire +3 more sources
Miryam Moreta-Rodríguez +3 more
openaire +5 more sources
Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials [PDF]
The coagulation system contributes greatly to the evolution of myocardial infarction (MI). Anticoagulation may reduce the occurrence of MI as monotherapy or with con- comitant use of aspirin.
Aradi, Dániel +3 more
core
Symptom‐controlled atrial fibrillation (AF), defined as asymptomatic or with mild symptoms according to the European Heart Rhythm Association (EHRA) score, was more common among Asians than in Europeans. In Asians, comorbidities of diabetes, hypertension, and prior ischemic stroke increase the likelihood of being scAF.
Wee Siong Teo +9 more
wiley +1 more source
Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in Denmark
ABSTRACT Objective Patients with polycythaemia vera (PV) may experience symptoms and cardiovascular complications before receiving a diagnosis. Understanding the associated patterns of healthcare and drug utilisation may help detect patients who need diagnostic workup.
Karoline Mathilde Lundgaard +4 more
wiley +1 more source

